Hudock Inc’s Prothena Corp PRTA Stock Holding History

Hudock Inc’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-28	Closed	-$1K	–	850
2021 Q3	$1K	Buy	+28	New	+$1.74K	﹤0.01%	809

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Hudock Inc's PRTA Position: Q4 2021 in Review

Hudock Inc sold out of Prothena Corp (PRTA) in Q4 2021, closing a stake of 28 shares — an estimated $1K sold.

Hudock Inc first reported a position in PRTA in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 196 funds tracked by Wall St. Rank hold PRTA as of Q4 2021.

Hudock Inc reported no remaining Prothena Corp position as of Q4 2021 after selling out during the quarter.
Hudock Inc sold 28 Prothena Corp shares in Q4 2021, an estimated $1K.
Hudock Inc first reported a position in Prothena Corp in Q3 2021 and held it in 1 quarter.
Hudock Inc's Prothena Corp position peaked at $1K in Q3 2021.
196 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2021.

Based on Hudock Inc's 13F filing for Q4 2021, filed 19 Jan 2022.